These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15131773)

  • 1. Inflexibility of energy substrate oxidation in type 1 diabetic patients.
    Wohl P; Wohl P; Girman P; Pelikánová T
    Metabolism; 2004 May; 53(5):655-9. PubMed ID: 15131773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary urea nitrogen excretion during the hyperinsulinemic euglycemic clamp in type 1 diabetic patients and healthy subjects.
    Wohl P; Krušinová E; Klementová M; Wohl P; Kratochvílová S; Pelikánová T
    Physiol Res; 2008; 57(2):247-252. PubMed ID: 17552877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eight weeks of overfeeding alters substrate partitioning without affecting metabolic flexibility in men.
    Peterson CM; Zhang B; Johannsen DL; Ravussin E
    Int J Obes (Lond); 2017 Jun; 41(6):887-893. PubMed ID: 28262678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate oxidation errors during combined indirect calorimetry-hyperinsulinemic glucose clamp studies.
    Thorburn AW; Gumbiner B; Flynn T; Henry RR
    Metabolism; 1991 Apr; 40(4):391-8. PubMed ID: 2011080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate source utilization during moderate intensity exercise with glucose ingestion in Type 1 diabetic patients.
    Robitaille M; Dubé MC; Weisnagel SJ; Prud'homme D; Massicotte D; Péronnet F; Lavoie C
    J Appl Physiol (1985); 2007 Jul; 103(1):119-24. PubMed ID: 17431081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation.
    Strączkowski M; Karczewska-Kupczewska M; Adamska A; Otziomek E; Kowalska I; Nikołajuk A
    Int J Obes (Lond); 2013 Oct; 37(10):1386-90. PubMed ID: 23419601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
    Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
    Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined hypertriglyceridemic and insulin-glucose clamps for the characterization of substrate oxidation and plasma elimination of a long-chain triglyceride emulsion in healthy men.
    Åberg V; Thörne A; Alvestrand A; Nordenström J
    Metabolism; 2012 Feb; 61(2):221-8. PubMed ID: 21864866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes.
    Perseghin G; Lattuada G; De Cobelli F; Esposito A; Costantino F; Canu T; Scifo P; De Taddeo F; Maffi P; Secchi A; Del Maschio A; Luzi L
    Diabetologia; 2005 Dec; 48(12):2615-21. PubMed ID: 16261312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
    Weyer C; Tataranni PA; Snitker S; Danforth E; Ravussin E
    Diabetes; 1998 Oct; 47(10):1555-61. PubMed ID: 9753292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T; Pratipanawatr W; Rosen C; Berria R; Bajaj M; Cusi K; Mandarino L; Kashyap S; Belfort R; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid turnover, substrate oxidation, and heat production in lean and obese cats during the euglycemic hyperinsulinemic clamp.
    Hoenig M; Thomaseth K; Waldron M; Ferguson DC
    Domest Anim Endocrinol; 2007 May; 32(4):329-38. PubMed ID: 16687234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal.
    Yokoyama H; Emoto M; Mori K; Araki T; Teramura M; Koyama H; Shoji T; Inaba M; Nishizawa Y
    J Clin Endocrinol Metab; 2006 Jan; 91(1):290-4. PubMed ID: 16234307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1.
    Perseghin G; Comola M; Scifo P; Benedini S; De Cobelli F; Lanzi R; Costantino F; Lattuada G; Battezzati A; Del Maschio A; Luzi L
    Am J Clin Nutr; 2004 Aug; 80(2):357-64. PubMed ID: 15277156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus.
    Orskov L; Møller N; Bak JF; Pørksen N; Schmitz O
    Metabolism; 1996 Feb; 45(2):211-7. PubMed ID: 8596492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of different insulin infusion rates on heart rate variability in lean and obese subjects.
    Paolisso G; Manzella D; Tagliamonte MR; Rizzo MR; Gambardella A; Varricchio M
    Metabolism; 1999 Jun; 48(6):755-62. PubMed ID: 10381151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism.
    Tessari P; Nosadini R; Trevisan R; De Kreutzenberg SV; Inchiostro S; Duner E; Biolo G; Marescotti MC; Tiengo A; Crepaldi G
    J Clin Invest; 1986 Jun; 77(6):1797-804. PubMed ID: 3519679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein metabolism in human obesity: relationship with glucose and lipid metabolism and with visceral adipose tissue.
    Solini A; Bonora E; Bonadonna R; Castellino P; DeFronzo RA
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2552-8. PubMed ID: 9253333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined insulin reduction and carbohydrate feeding strategy 30 min before running best preserves blood glucose concentration after exercise through improved fuel oxidation in type 1 diabetes mellitus.
    West DJ; Stephens JW; Bain SC; Kilduff LP; Luzio S; Still R; Bracken RM
    J Sports Sci; 2011 Feb; 29(3):279-89. PubMed ID: 21154013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.